New Zealand - Ingliż - Medsafe (Medicines Safety Authority)

rex medical ltd - montelukast sodium 5.19mg equivalent to 5 mg montelukast free acid - chewable tablet - 5 mg - active: montelukast sodium 5.19mg equivalent to 5 mg montelukast free acid excipient: aspartame cherry flavour 11035-31 croscarmellose sodium hyprolose iron oxide red magnesium stearate mannitol microcrystalline cellulose - montelukast is indicated in adult and paediatric patients 2 years of age and older for the prophylaxis and chronic treatment of asthma, including the prevention of day- and night-time symptoms and the prevention of exercise-induced bronchospasm. montelukast is indicated in adults and paediatric patients 2 years of age and older for the relief of daytime and night time symptoms of seasonal allergic rhinitis and perennial allergic rhinitis.

New Zealand - Ingliż - Medsafe (Medicines Safety Authority)

viatris limited - montelukast sodium 5.19mg equivalent to montelukast 5 mg - chewable tablet - 5 mg - active: montelukast sodium 5.19mg equivalent to montelukast 5 mg excipient: aspartame cherry flavour 501027 ap0551 colloidal silicon dioxide croscarmellose sodium stear-o-wet m mannitol microcrystalline cellulose - indicated in paediatric patients 6 to 14 years of age for the relief of daytime and night-time symptoms of seasonal allergic rhinitis and perennial allergic rhinitis.

Kanada - Ingliż - Health Canada

apotex inc - montelukast (montelukast sodium) - tablet (chewable) - 5mg - montelukast (montelukast sodium) 5mg - leukotriene modifiers

Kanada - Ingliż - Health Canada

auro pharma inc - montelukast (montelukast sodium) - tablet (chewable) - 5mg - montelukast (montelukast sodium) 5mg - leukotriene modifiers

Kanada - Ingliż - Health Canada

apotex inc - montelukast (montelukast sodium) - tablet (chewable) - 4mg - montelukast (montelukast sodium) 4mg - leukotriene modifiers

Kanada - Ingliż - Health Canada

auro pharma inc - montelukast (montelukast sodium) - tablet (chewable) - 4mg - montelukast (montelukast sodium) 4mg - leukotriene modifiers

Iżrael - Ingliż - Ministry of Health

abic marketing ltd, israel - montelukast as sodium - film coated tablets - montelukast as sodium 10 mg - montelukast - montelukast - montelukast teva is indicated in adult and adolescents 15 years of age and older for the prophylaxis and chronic treatment of asthma including prevention of daytime and nighttime symptoms the treatment of aspirin-sensitive asthmatic patients and the prevention of exercise-induced bronchoconstriction. montelukast teva is effective alone or in combination with other agents used in the maintenance treatment of chronic asthma. montelukast teva and inhaled corticosteroids may be used concomitantly with additive effects to control asthma or to reduce the inhaled corticosteroid dose while maintaining clinical stability. montelukast teva is indicated for the relief of symptoms of seasonal allergic rhinitis in adults and adolescents 15 years of age and older.

Iżrael - Ingliż - Ministry of Health

trima israel pharmaceutical products maabarot ltd - montelukast as sodium salt - chewable tablets - montelukast as sodium salt 4 mg - montelukast - montelukast - montelukast - trima is indicated in adult and pediatric patients 2 years of age and older for the prophylaxis and chronic treatment of asthma, including prevention of daytime and nighttime symptoms, the treatment of aspirin-sensitive asthmatic patients, and the prevention of exercise-induced bronchoconstriction. montelukast - trima is effective alone or in combination with other agents used in the maintenance treatment of chronic asthma. montelukast - trima and inhaled corticosteroids may be used concomitantly with additive effects to control asthma or to reduce the inhaled corticosteroid dose while maintaining clinical stability. montelukast - trima is indicated for the relief of symptoms of seasonal allergic rhinitis in adults and pediatric patients 2 years of age and older.

Iżrael - Ingliż - Ministry of Health

trima israel pharmaceutical products maabarot ltd - montelukast as sodium salt - chewable tablets - montelukast as sodium salt 5 mg - montelukast - montelukast - montelukast - trima is indicated in adult and pediatric patients 2 years of age and older for the prophylaxis and chronic treatment of asthma, including prevention of daytime and nighttime symptoms, the treatment of aspirin-sensitive asthmatic patients, and the prevention of exercise-induced bronchoconstriction. montelukast - trima is effective alone or in combination with other agents used in the maintenance treatment of chronic asthma. montelukast - trima and inhaled corticosteroids may be used concomitantly with additive effects to control asthma or to reduce the inhaled corticosteroid dose while maintaining clinical stability. montelukast - trima is indicated for the relief of symptoms of seasonal allergic rhinitis in adults and pediatric patients 2 years of age and older.

Iżrael - Ingliż - Ministry of Health

trima israel pharmaceutical products maabarot ltd - montelukast as sodium salt - tablets - montelukast as sodium salt 10 mg - montelukast - montelukast - montelukast - trima is indicated in adult and pediatric patients 2 years of age and older for the prophylaxis and chronic treatment of asthma, including prevention of daytime and nighttime symptoms, the treatment of aspirin-sensitive asthmatic patients, and the prevention of exercise-induced bronchoconstriction. montelukast - trima is effective alone or in combination with other agents used in the maintenance treatment of chronic asthma. montelukast - trima and inhaled corticosteroids may be used concomitantly with additive effects to control asthma or to reduce the inhaled corticosteroid dose while maintaining clinical stability. montelukast - trima is indicated for the relief of symptoms of seasonal allergic rhinitis in adults and pediatric patients 2 years of age and older.